He has a research background and has worked in and for the healthcare industry for over 26 years. He held various management positions over a ten-year period with Eli Lilly in areas such as New Product Planning, Business Development and Marketing. He left Lilly to join Rorer Healthcare in the UK, where he was Strategic Planning Director and a member of their Executive Committee.
Martyn has been a Principal in both KPMG’s and Coopers & Lybrand’s consulting divisions where he led their respective pharmaceutical marketing and strategy consulting efforts. Prior to founding Cambridge Healthcare & Biotech has was a Senior Vice President of Cambridge Pharma Consultancy, where he led their Business and Marketing Strategy Group.
Martyn spent 3 years with Dresdner Kleinwort Benson, where he was responsible for healthcare M&A projects based out of the bank’s London, Frankfurt and New York offices.
Martyn is currently a Co-chair of the UKTI's Taiwan Britain Business Council and is a guest lecturer at the University of Cambridge's Institute of Biotechnology
Martyn has advised over 70 different healthcare companies in a diverse range of projects including mergers, acquisitions, due diligence, licensing, marketing and general business strategy. |
